image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

SIGN UP NOW
Updates

Plus500 - Shares surge towards £15

October 2020

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • PLUS
  • Price:
  • 1459p
Plus500, the leading technology platform for trading CFDs, announced blockbuster interim results, sending the shares soaring above £15.Covid-19 related volatility in the markets has helped drive an amazing 281% increase in revenues to US$564m (derived from customer spreads and overnight charges) with EBITDA growing 452% to US$361.8m. Earnings per share rose from 45 cents to 298 cents. The scalability of its platform (spreading rising revenues over a relatively fixed cost base) saw EBITDA margins spike violently from 44% to 64%! Profitability was also boosted by a 41% reduction in customer acquisition costs from US$1,079 to US$634.With market leadership strengthened in key regions such as UK, Germany and Spain, the number of a ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Plus500 - CFD trading firm enjoys double-digit upgrade (February 2024)
Plus500 (September 2021)
Plus500 (June 2021)
Plus500 (April 2021)
Plus500 (December 2020)
Plus500 (November 2020)
Plus500 - Q2 revenues up 162%! (September 2020)
Plus500 (August 2020)
Plus500 - Second upgrade in a month (June 2020)
Plus500 - Significant director buying (April 2020)
Plus500 (February 2020)
Plus500 - Shares very cheap on ex-cash PE of 5.3 (December 2019)
Plus500 (September 2017)
Plus500 (January 2017)
Plus500 - Soon-to-be prospective PE just 6.6 (December 2016)
Plus500 - CFD trading firm a serious rival to IG (October 2016)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X